下肢血运重建后以缺血为导向的冠状动脉血运重建可改善慢性肢体威胁性缺血患者的5年生存率
前瞻性队列研究纳入无心脏病史或症状的慢性肢体威胁性缺血(CLTI)患者,比较术前冠状动脉CT血管成像(CTA)及CT衍生血流储备分数(FFRCT)评估并选择性术后冠状动脉血运重建(FFRCT组,n=111)与标准术前评估且未行术后冠状动脉血运重建(对照组,n=120)的5年结局。FFRCT组全因死亡、心源性死亡、心肌梗死及主要不良心血管事件均少于对照组,5年生存率提高(76% vs 53%,p<0.001)。
要点
- FFRCT组69%患者存在无症状冠状动脉缺血(FFRCT≤0.80),58%为严重缺血(FFRCT≤0.75)。
- FFRCT组42%患者下肢血运重建后行择期冠状动脉血运重建,对照组无择期冠状动脉血运重建。
- 5年随访FFRCT组全因死亡24% vs 对照组47%(HR=0.43,95%CI 0.27-0.69,p<0.001)。
核心结论
- 下肢血运重建后对CLTI患者无症状冠状动脉缺血行缺血导向的冠状动脉血运重建,与标准心脏评估和护理相比,全因死亡、心源性死亡、心肌梗死和MACE减少2倍以上,5年生存率提高(76% vs 53%,p<0.001)。
- 作者认为术后择期FFRCT指导的冠状动脉血运重建可减少不良心脏事件并改善长期生存,但需随机研究最终验证该概念。
研究设计与样本
- 前瞻性队列研究,纳入无心脏病史或症状、接受择期下肢血运重建的CLTI患者。
- FFRCT组(n=111)术前接受冠状动脉CTA和FFRCT评估并选择性术后冠状动脉血运重建;对照组(n=120)接受标准术前评估且无术后冠状动脉血运重建。
- 特异性冠状动脉缺血定义为冠状动脉狭窄远端FFRCT≤0.80,FFRCT≤0.75提示严重缺血。
- 两组均接受指南导向药物治疗,随访5年。
主要发现
- FFRCT组FFRCT分析显示无症状冠状动脉缺血(FFRCT≤0.80)者占69%,严重缺血(FFRCT≤0.75)者占58%,左主干缺血者占8%,多支血管缺血者占40%。
- 对照组冠状动脉缺血状态未知。
- FFRCT组42%患者下肢血运重建后行择期冠状动脉血运重建,对照组无择期血运重建。
- 5年随访FFRCT组较对照组全因死亡少(24% vs 47%,HR=0.43,95%CI 0.27-0.69,p<0.001)。
- 5年随访FFRCT组较对照组心源性死亡少(5% vs 26%,HR=0.18,95%CI 0.07-0.45,p<0.001)、心肌梗死少(7% vs 28%,HR=0.21,95%CI 0.10-0.47,p<0.001)、MACE少(14% vs 39%,HR=0.28,95%CI 0.15-0.51,p<0.001)。
关键数值与推荐
- 冠状动脉缺血定义为FFRCT≤0.80,严重缺血定义为FFRCT≤0.75。
- MACE定义为心血管死亡、心肌梗死、卒中或非计划冠状动脉血运重建。
- 5年生存率FFRCT组76% vs 对照组53%(p<0.001)。
临床怎么用
- 作者认为FFRCT是围术期诊断无症状冠状动脉缺血的便捷工具。
- 作者建议术后择期FFRCT指导的冠状动脉血运重建可减少不良心脏事件并改善长期生存,但需随机研究最终验证。
局限性
- 对照组冠状动脉缺血状态未知。
- 作者指出需随机研究最终验证该概念。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine whether diagnosis of asymptomatic (silent) coronary ischemia using coronary computed tomography (CT)-derived fractional flow reserve (FFRCT) together with targeted coronary revascularization of ischemia-producing coronary lesions following lower-extremity revascularization can reduce adverse cardiac events and improve long-term survival of patients with chronic limb-threatening ischemia (CLTI). MATERIALS AND METHODS: Prospective cohort study of CLTI patients with no cardiac history or symptoms undergoing elective lower-extremity revascularization. Patients with pre-operative coronary computed tomography angiography (CTA) and FFRCT evaluation with selective post-operative coronary revascularization (FFRCT group) were compared with patients with standard pre-operative evaluation and no post-operative coronary revascularization (control group). Lesion-specific coronary ischemia was defined as FFRCT≤0.80 distal to a coronary stenosis with FFRCT≤0.75 indicating severe ischemia. Endpoints included all-cause death, cardiac death, myocardial infarction (MI) and major adverse cardiovascular (CV) events (MACE=CV death, MI, stroke, or unplanned coronary revascularization) during 5 year follow-up. RESULTS: In the FFRCT group (n=111), FFRCT analysis revealed asymptomatic (silent) coronary ischemia (FFRCT≤0.80) in 69% of patients, with severe ischemia (FFRCT≤0.75) in 58%, left main ischemia in 8%, and multivessel ischemia in 40% of patients. The status of coronary ischemia in the control group (n=120) was unknown. Following lower-extremity revascularization, 42% of patients in FFRCT had elective coronary revascularization with no elective revascularization in controls. Both groups received guideline-directed medical therapy. During 5 year follow-up, compared with control, the FFRCT group had fewer all-cause deaths (24% vs 47%, hazard ratio [HR]=0.43 [95% confidence interval [CI]=0.27-0.69], p<0.001), fewer cardiac deaths (5% vs 26%, HR=0.18 [95% CI=0.07-0.45], p<0.001), fewer MIs (7% vs 28%, HR=0.21 [95% CI=0.10-0.47], p<0.001), and fewer MACE events (14% vs 39%, HR=0.28 [95% CI=0.15-0.51], p<0.001). CONCLUSIONS: Ischemia-guided coronary revascularization of CLTI patients with asymptomatic (silent) coronary ischemia following lower-extremity revascularization resulted in more than 2-fold reduction in all-cause death, cardiac death, MI, and MACE with improved 5 year survival compared with patients with standard cardiac evaluation and care (76% vs 53%, p<0.001).Clinical ImpactSilent coronary ischemia in patients with chronic limb-threatening ischemia (CLTI) is common even in the absence of cardiac history or symptoms. FFRCT is a convenient tool to diagnose silent coronary ischemia perioperatively. Our data suggest that post-surgery elective FFRCT-guided coronary revascularization reduces adverse cardiac events and improves long-term survival in this very-high risk patient group. Randomized study is warranted to finally test this concept.
引用
- Latkovskis G, Krievins D, Zellans E, et al. Ischemia-Guided Coronary Revascularization Following Lower-Extremity Revascularization Improves 5-Year Survival of Patients With Chronic Limb-Threatening Ischemia. J Endovasc Ther. 2024. PMID: 38616613. doi:10.1177/15266028241245909
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。